Novel Combination Inhaler for Asthma Heads to FDA Panel

(MedPage Today) -- The FDA's Pulmonary-Allergy Drugs Advisory Committee on Tuesday will consider whether a novel two-drug combination inhaler for asthma should be the first FDA-approved product containing an inhaled corticosteroid (budesonide...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news